Granulocyte and monocyte adsorptive apheresis for ulcerative colitis in a patient with low bone mineral density due to Fanconi-Bickel syndrome

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Systemic steroid is required for the exacerbation of ulcerative colitis (UC), although its administration should be avoided in patients with a low bone mineral density (BMD) exacerbated by side effects of steroids. We herein report the successful induction of remission in an UC case with a low BMD due to Fanconi-Bickel syndrome-or glycogen storage disease type XI-using granulocyte and monocyte adsorptive apheresis (GMA). For a 43-year-old woman with a BMD of 50% the young adult mean, GMA was performed 2 times a week for a total of 10 times. GMA might be a steroid-free treatment option for UC patients with a low BMD.

Cite

CITATION STYLE

APA

Tanaka, M., Nakanishi, M., Miyazaki, H., Morita, R., Eguchi, H., Takeda, Y., … Shigematsu, T. (2021). Granulocyte and monocyte adsorptive apheresis for ulcerative colitis in a patient with low bone mineral density due to Fanconi-Bickel syndrome. Internal Medicine, 60(15), 2413–2417. https://doi.org/10.2169/internalmedicine.6707-20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free